Optibrium receives further investment from Kester Capital

Optibrium receives further investment from Kester Capital   Second round of funding from existing investors will further drive company expansion and commercial growth of its AI-enabled drug discovery technology. CAMBRIDGE, UK, 21 June 2022 – Optibrium™, a developer of...

Optimising Operations & Processes in Biotech Labs

Optimising Operations & Processes in Biotech Labs Recent developments in computational tools and how these can solve operational challenges in biotech labs. Interview published by Lab Manager: – Biotechnology labs face many challenges, such as operations and...